Heidi Swygard, MD

Medical Director, ViiV Healthcare
ViiV Healthcare

Disclosure(s): ViiV Healthcare: Employee, Stocks/Bonds (Private Company)

Poster(s):

• (P-313) Black Women’s Experiences on Long-Acting Cabotegravir for PrEP: Interim Patient Findings from the EBONI Study
  Monday, October 20, 2025

  12:15 PM - 1:30 PM US ET